SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced its clinical informatics platform Alissa Interpret has been adopted by the North West Genomic Laboratory Hub (NW GLH) based in Manchester and Liverpool, part of Manchester University NHS Foundation Trust, England. The NW GLH and its partners are responsible for delivering genomic testing across the whole of the North [...]

Sherry Buck to Step Down as CFO, Effective December 31, 2020 Michael Silveira Appointed Interim CFO, Effective January 1, 2021 MILFORD, Mass. -- Waters Corporation (NYSE:WAT) today announced that Sherry Buck will step down as Chief Financial Officer, effective December 31, 2020, in order to pursue another opportunity at a privately held company. Upon her departure, Michael F. [...]

Optibrium, Intellegens and Medicines Discovery Catapult combine their expertise in drug discovery and AI research CAMBRIDGE, and MACCLESFIELD, UK – The consortium behind the DeepADMET project set up to advance artificial intelligence (AI) technologies for drug discovery, today announced the successful conclusion of this project which was funded by Innovate UK, the UK’s innovation agency. Optibrium [...]

PRINCETON, NJ. – Certara, Inc. (“Certara”) today announced the launch of its initial public offering of 24,390,000 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 14,630,000 shares of common stock and certain selling stockholders are offering 9,760,000 shares of common stock in [...]

Associated Collaboration with the New York Genome Center to Expand Patient Access to Advanced Genomic Technologies New York — Seeking to advance the scope of precision medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, and Illumina, Inc. are entering into a collaboration to sequence the complete human genomes of thousands of consenting patients, in order to identify genetic alterations driving disease [...]

Smart functions and tools optimize productivity and efficiency SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced a new ICP-MS instrument, the Agilent 7850 ICP-MS System, that provides new smart tools to minimize common time traps that can affect ICP-MS analysis workflows. Building on decades of innovation, the 7850 ICP-MS combines market-leading performance with new [...]

Continued expansion of clinical products further advances precision medicine globally The NextSeq 550Dx received approval from China’s National Medical Products Administration (NMPA) for genetic testing and diagnosis, paving the way toward improved patient outcomes by harnessing the power of next-generation sequencing. Since obtaining United States FDA approval in 2017, the NextSeq 550Dx has been cleared [...]

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics (NASDAQ: RGLS) announced a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326, an Autosomal Dominant Polycystic Kidney Disease (ADPKD) treatment. Regulus has utilized two Bio-Techne branded product lines, ProteinSimple and Exosome Diagnostics, to aid in their clinical trial patient testing.  RGLS4326 [...]

The partnership launches RoosterBio’s first international platform with off-the-shelf working cell banks and hMSC bioprocess media products in Asia FREDERICK, Md. -- RoosterBio, Inc, a leading supplier of innovative cellular therapy bioprocess tools and scalable manufacturing solutions for regenerative medicine, today announced it entered into an exclusive agency agreement with Sartorius Korea Biotech, a subsidiary of the [...]

DUBLIN, Ireland & Frankfurt a.M., Germany: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Vivlion GmbH, a startup company providing next generation CRISPR/Cas gRNA libraries and screening services for the global R&D market, today announced a non-exclusive license agreement granting Vivlion® [...]